A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...

Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...

Dry skin, itching, and fiery eczema can be caused by allergens, stress, or an overactive immune response.Steroid creams ...

Topical Steroid Withdrawal Diagnostic Criteria Defined by NIH Researchers - Criteria May Help Guide Treatment of Dermatitis ...

Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease ...

The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to severe atopic dermatitis, introducing a novel mechanism to treat ...

This NIHR Collection brings together major studies on the prevention and treatment of childhood eczema. It finds that many ...

NIH researchers define diagnostic criteria for topical steroid withdrawal (TSW), distinguishing it from eczema.

Despite multiple treatments for eczema and pityriasis alba, a child’s skin condition worsened until a biopsy revealed mycosis ...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...